Published in Osteoporos Int on December 31, 2005
Osteogenesis and osteoclast inhibition in rheumatoid arthritis patients treated with bisphosphonates alone or in combination with pitavastatin over an 18-month follow-up after more than 4 years of treatment with bisphosphonates. Arthritis Res Ther (2012) 0.75
[New pathophysological relevant metabolic pathways in osteoporosis. Future innovative therapies?]. Z Rheumatol (2006) 0.75
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell (1998) 17.76
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell (1997) 15.96
osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev (1998) 7.81
The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res (2000) 3.38
Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. JAMA (2004) 3.35
Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis. Endocrinology (1999) 2.69
Effect of estrogen versus testosterone on circulating osteoprotegerin and other cytokine levels in normal elderly men. J Clin Endocrinol Metab (2002) 1.96
Serum osteoprotegerin levels in healthy controls and cancer patients. Clin Cancer Res (2002) 1.88
Prevention of bone loss after allogeneic stem cell transplantation by calcium, vitamin D, and sex hormone replacement with or without pamidronate. J Clin Endocrinol Metab (2005) 1.62
The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts. Bone (2003) 1.51
Pamidronate is an effective treatment for osteoporosis in patients with beta-thalassaemia. Br J Haematol (2003) 1.49
Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts. Biochem Biophys Res Commun (2002) 1.35
Bone loss following hematopoietic stem cell transplantation: a long-term follow-up. Blood (2003) 1.05
Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation. J Bone Miner Res (1999) 1.04
Bisphosphonates regulate cell growth and gene expression in the UMR 106-01 clonal rat osteosarcoma cell line. Br J Cancer (2001) 1.00
Serum osteoprotegerin and its ligand in Paget's disease of bone: relationship to disease activity and effect of treatment with bisphosphonates. Arthritis Rheum (2003) 0.97
Osteoporosis after solid organ and bone marrow transplantation. Osteoporos Int (2003) 0.97
The nitrogen-containing bisphosphonate, zoledronic acid, influences RANKL expression in human osteoblast-like cells by activating TNF-alpha converting enzyme (TACE). J Bone Miner Res (2004) 0.96
Mechanisms of glucocorticoid-induced osteoporosis. Curr Opin Rheumatol (2003) 0.96
High-dose chemotherapy shows a dose-dependent toxicity to bone marrow osteoprogenitors: a mechanism for post-bone marrow transplantation osteopenia. Cancer (2001) 0.95
Bone loss in long-term survivors after transplantation of hematopoietic stem cells: a prospective study. Osteoporos Int (2000) 0.93
Clinical review 165: Markers of bone remodeling in metastatic bone disease. J Clin Endocrinol Metab (2003) 0.93
Post-transplantation bone disease: the role of immunosuppressive agents and the skeleton. J Bone Miner Res (1996) 0.92
The effect of bone marrow transplantation on the osteoblastic differentiation of human bone marrow stromal cells. J Clin Endocrinol Metab (2002) 0.91
A prospective study of bone loss and turnover after allogeneic bone marrow transplantation: effect of calcium supplementation with or without calcitonin. Bone Marrow Transplant (1999) 0.90
The short-term changes of bone mineral metabolism following bone marrow transplantation. Bone (2000) 0.88
Serum osteoprotegerin is a major determinant of bone density development and prevalent vertebral fracture status following cardiac transplantation. Bone (2003) 0.86
Inhibitory action of bisphosphonates on bone resorption does not involve the regulation of RANKL and OPG expression. Exp Mol Med (2002) 0.86
Recovery of bone mass and normalization of bone turnover in long-term survivors of allogeneic bone marrow transplantation. Bone Marrow Transplant (2002) 0.86
The role of cytokines in the changes in bone turnover following bone marrow transplantation. Osteoporos Int (2002) 0.84
Growth failure and growth hormone deficiency in children after bone marrow transplantation for leukemia. Bone Marrow Transplant (1990) 0.82
Therapy of osteoporosis in patients with Crohn's disease: a randomized study comparing sodium fluoride and ibandronate. Aliment Pharmacol Ther (2003) 0.81
Changes in the serum growth factors and osteoprotegerin after bone marrow transplantation: impact on bone and mineral metabolism. J Clin Endocrinol Metab (2004) 0.81
Osteoprotegerin levels before and after renal transplantation. Am J Kidney Dis (2001) 0.78
Pituitary size assessed with magnetic resonance imaging as a measure of growth hormone secretion in long term survivors of childhood cancer. J Clin Endocrinol Metab (1994) 0.78
Serum osteoprotegerin levels in patients after liver transplantation and correlation to bone turnover, bone mineral density and fracture status. Wien Klin Wochenschr (2002) 0.76
Osteoprotegerin and its correlations with new markers of bone formation and bone resorption in kidney transplant recipients. Transplant Proc (2003) 0.75
Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics. Cancer Res (1998) 2.33
Hepatosplenic candidiasis in patients with acute leukemia: incidence and prognostic implications. Clin Infect Dis (1997) 2.08
[Should our daily D-vitamin intake be increased?]. Duodecim (2000) 2.03
Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11. Cancer Res (1996) 1.99
Maternal vitamin D status determines bone variables in the newborn. J Clin Endocrinol Metab (2010) 1.80
Impact of maternal atopy and probiotic supplementation during pregnancy on infant sensitization: a double-blind placebo-controlled study. Clin Exp Allergy (2008) 1.79
Identification of a gene at 11q23 encoding a guanine nucleotide exchange factor: evidence for its fusion with MLL in acute myeloid leukemia. Proc Natl Acad Sci U S A (2000) 1.69
Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group. Bone Marrow Transplant (1990) 1.65
Collection, cryopreservation and subsequent viability of haemopoietic stem cells intended for treatment of chronic granulocytic leukaemia in blast-cell transformation. Br J Haematol (1978) 1.55
Maternal breast-milk and intestinal bifidobacteria guide the compositional development of the Bifidobacterium microbiota in infants at risk of allergic disease. Clin Exp Allergy (2007) 1.49
Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemia. Blood (1996) 1.49
Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of a cytokine response. Microb Pathog (1996) 1.41
Variation in dimethyl sulfoxide use in stem cell transplantation: a survey of EBMT centres. Bone Marrow Transplant (2005) 1.40
Splenic irradiation before bone marrow transplantation for chronic myeloid leukaemia. Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT) Br J Haematol (1996) 1.40
Colony formation by megakaryocyte progenitors in myelodysplatic syndromes. Eur J Haematol (1989) 1.39
Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983--93 and 1994--8 at European Group for Blood and Marrow Transplantation centres. Br J Haematol (2001) 1.36
The impact of perinatal probiotic intervention on the development of overweight and obesity: follow-up study from birth to 10 years. Int J Obes (Lond) (2010) 1.31
Chlamydia pneumoniae infection in human monocytes. Infect Immun (1999) 1.28
Expression of adhesion molecules on endothelial cells stimulated by Chlamydia pneumoniae. Microb Pathog (1996) 1.25
Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemia. Leukemia (2011) 1.24
Allogeneic stem cell transplantation for older advanced MDS patients: improved survival with young unrelated donor in comparison with HLA-identical siblings. Leukemia (2012) 1.23
Bifidobacterium and Lactobacillus DNA in the human placenta. Lett Appl Microbiol (2008) 1.19
Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients. Bone Marrow Transplant (1997) 1.19
Comparison of conditioning regimens of various intensities for allogeneic hematopoietic SCT using HLA-identical sibling donors in AML and MDS with <10% BM blasts: a report from EBMT. Bone Marrow Transplant (2012) 1.16
Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs. J Bone Miner Res (1994) 1.14
Monosomy 7 in granulocytes and monocytes in myelodysplastic syndrome. N Engl J Med (1987) 1.14
Isolated HLA-C mismatches in unrelated donor transplantation for CML. Bone Marrow Transplant (2004) 1.12
Dual-energy X-ray absorptiometry in normal women: a cross-sectional study of 717 Finnish volunteers. Osteoporos Int (1992) 1.12
Differences between graft product and donor side effects following bone marrow or stem cell donation. Bone Marrow Transplant (2003) 1.11
Chlamydia pneumoniae multiplies in human endothelial cells in vitro. Microb Pathog (1994) 1.10
Experimental infection of Chlamydia pneumoniae in mice. Microb Pathog (1993) 1.08
Gender-associated differences in the quality of life after allogeneic BMT. Bone Marrow Transplant (2001) 1.08
Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the Chronic Leukemia Working Party of the EBMT. Bone Marrow Transplant (2009) 1.07
Erythroid and granulocyte-macrophage colony formation in myelodysplastic syndromes. Scand J Haematol (1984) 1.03
Cardiac involvement in bone marrow transplantation: electrocardiographic changes, arrhythmias, heart failure and autopsy findings. Bone Marrow Transplant (1990) 1.01
Detection of residual host cells after bone marrow transplantation using non-isotopic in situ hybridization and karyotype analysis. Bone Marrow Transplant (1993) 1.01
Efficacy and safety of prolonged-release lanreotide in patients with gastrointestinal neuroendocrine tumors and hormone-related symptoms. J Clin Oncol (1999) 1.00
Chromosome 7 long arm deletion in myeloid disorders: a narrow breakpoint region in 7q22 defined by molecular mapping. Blood (1989) 1.00
Bone mineral density measured by dual-energy X-ray absorptiometry in normal men. Eur J Clin Invest (1992) 0.99
High incidence of PTLD after non-T-cell-depleted allogeneic haematopoietic stem cell transplantation as a consequence of intensive immunosuppressive treatment. Bone Marrow Transplant (2003) 0.99
Defective chemotaxis in monosomy-7. Nature (1977) 0.99
Monosomal karyotype predicts poor survival after allogeneic stem cell transplantation in chromosome 7 abnormal myelodysplastic syndrome and secondary acute myeloid leukemia. Leukemia (2012) 0.98
The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplants. Bone Marrow Transplant (2005) 0.98
Outbreaks of infectious diseases in stem cell transplant units: a silent cause of death for patients and transplant programmes. Bone Marrow Transplant (2004) 0.98
Invasive cutaneous mucormycosis caused by Absidia corymbifera after allogeneic bone marrow transplantation. Bone Marrow Transplant (1996) 0.97
Autosomal dominant erythrocytosis caused by increased sensitivity to erythropoietin. Blood (1991) 0.97
Non-transferrin-bound iron during allogeneic stem cell transplantation. Br J Haematol (2001) 0.97
In a high-dose melphalan setting, palifermin compared with placebo had no effect on oral mucositis or related patient's burden. Bone Marrow Transplant (2012) 0.96
Overgrowth of Enterococcus faecium in the feces of patients with hematologic malignancies. Clin Infect Dis (1996) 0.96
An outbreak of invasive aspergillosis in a haematologic unit. Scand J Infect Dis (1987) 0.96
Quality of life and factors related to perceived satisfaction with quality of life after allogeneic bone marrow transplantation. Ann Hematol (2001) 0.96
Melanocortin-3-receptor gene variants in morbid obesity. Int J Obes Relat Metab Disord (2003) 0.95
Function of neutrophils in preleukaemia. Scand J Haematol (1977) 0.95
Late non-relapse mortality among adult autologous stem cell transplant recipients: a nation-wide analysis of 1,482 patients transplanted in 1990-2003. Eur J Haematol (2006) 0.94
Hepatosplenic yeast infection in patients with acute leukemia: a diagnostic problem. Clin Infect Dis (1994) 0.94
Experimental Chlamydia pneumoniae infection in mice: effect of reinfection and passive immunization. Microb Pathog (1995) 0.94
Collection of autologous blood for bone marrow donation: how useful is it? Bone Marrow Transplant (2005) 0.93
Modulation of the maturing gut barrier and microbiota: a novel target in allergic disease. Curr Pharm Des (2008) 0.92
Chlamydia pneumoniae does not increase atherosclerosis in the aortic root of apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol (2001) 0.92
Role of plasma vasopressin in changes of water balance accompanying acute alcohol intoxication. Alcohol Clin Exp Res (1995) 0.92
Dietary and clinical impacts of nausea and vomiting during pregnancy. J Hum Nutr Diet (2009) 0.92
Use of bronchoalveolar lavage cytology and determination of protein contents in pulmonary complications of bone marrow transplant recipients. Bone Marrow Transplant (1990) 0.92
Impact of maternal diet during pregnancy and breastfeeding on infant metabolic programming: a prospective randomized controlled study. Eur J Clin Nutr (2010) 0.92
The Prospective Oral Mucositis Audit: relationship of severe oral mucositis with clinical and medical resource use outcomes in patients receiving high-dose melphalan or BEAM-conditioning chemotherapy and autologous SCT. Bone Marrow Transplant (2008) 0.91
Heme arginate treatment for myelodysplastic syndromes. Leuk Res (1988) 0.91
Epstein-Barr viral load and disease prediction in a large cohort of allogeneic stem cell transplant recipients. Clin Infect Dis (2007) 0.91
Alpha-interferon maintenance treatment is associated with improved survival after high-dose treatment and autologous stem cell transplantation in patients with multiple myeloma: a retrospective registry study from the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant (2001) 0.90
A prospective study of bone loss and turnover after allogeneic bone marrow transplantation: effect of calcium supplementation with or without calcitonin. Bone Marrow Transplant (1999) 0.90
Early treatment-related mortality in adult autologous stem cell transplant recipients: a nation-wide survey of 1482 transplanted patients. Eur J Haematol (2006) 0.90
The prognostic value of in vitro cultures of erythroid and megakaryocyte progenitors in myelodysplastic syndromes. Leuk Res (1999) 0.90
A high prevalence of hypovitaminosis D in Finnish medical in- and outpatients. J Intern Med (2001) 0.89